Clinical Trial Update: Disparities in the Proportion of Ticagrelor and Prasugrel-eligible Patients with Acute Coronary Syndrome in a Real-world Registry

View source ↗

Summary

This real-world registry analysis reports disparities in the proportion of acute coronary syndrome patients eligible for ticagrelor or prasugrel.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: University Hospital Heidelberg | Conditions: Acute Myocardial Infarction | Status: COMPLETED